| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/21/1999 | WO1999002718A1 INFECTIOUS VECTORS AND CLONES OF PLANTS DERIVED FROM THE TURNIP MOSAIC VIRUS (TuMV) |
| 01/21/1999 | WO1999002717A1 Chimeric gene coding for drosomicine, vector containing it and production of transgenic plants resistant to diseases |
| 01/21/1999 | WO1999002716A1 Increased production of secreted proteins by recombinant yeast cells |
| 01/21/1999 | WO1999002715A1 SPLICE VARIANTS OF BRCA1 AND $i(BRCA2) |
| 01/21/1999 | WO1999002713A1 Pseudomonas exotoxin a-like chimeric immunogens |
| 01/21/1999 | WO1999002711A2 Fusion proteins with an immunoglobulin hinge region linker |
| 01/21/1999 | WO1999002710A1 Production and use of recombinant protein multimers with altered biological activity |
| 01/21/1999 | WO1999002708A1 Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein |
| 01/21/1999 | WO1999002707A1 Fusion proteins comprising coiled-coil structures |
| 01/21/1999 | WO1999002705A1 CLONING OF THE PROLYL-DIPEPTIDYL-PEPTIDASE FROM $i(ASPERGILLUS ORYZAE) |
| 01/21/1999 | WO1999002704A2 Dual specifically phosphatase and methods of use |
| 01/21/1999 | WO1999002703A1 Fumonisin detoxification compositions and methods |
| 01/21/1999 | WO1999002702A1 MUTANT α-AMYLASE HAVING INTRODUCED THEREIN A DISULFIDE BOND |
| 01/21/1999 | WO1999002701A1 Pak kinase genes and polypeptides and methods of use thereof |
| 01/21/1999 | WO1999002700A1 HISTIDINE KINASE TWO-COMPONENT IN $i(CANDIDA ALBICANS) |
| 01/21/1999 | WO1999002699A1 Kds protein kinase molecules and uses related thereto |
| 01/21/1999 | WO1999002698A1 Rna polymerase |
| 01/21/1999 | WO1999002697A1 Mutant bioluminescent protein and process for producing the mutant bioluminescent protein |
| 01/21/1999 | WO1999002696A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | WO1999002695A2 Epitopes and active sites of paramyxoviridae proteins and uses thereof |
| 01/21/1999 | WO1999002694A1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| 01/21/1999 | WO1999002693A2 Microbial swollenin protein; dna sequences encoding such swollenins and method of producing such swollenins |
| 01/21/1999 | WO1999002692A1 TEMPERATURE SENSITIVE dtsR GENES |
| 01/21/1999 | WO1999002691A1 Enhanced expression of proteolytic enzymes in koji mold |
| 01/21/1999 | WO1999002690A1 Systemin |
| 01/21/1999 | WO1999002689A1 Plant sug1 homologs |
| 01/21/1999 | WO1999002688A1 Coffee storage proteins |
| 01/21/1999 | WO1999002687A1 Method of increasing the iron content of plant cells |
| 01/21/1999 | WO1999002686A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | WO1999002685A1 Interleukin-3 gene therapy for cancer |
| 01/21/1999 | WO1999002684A1 Methods of identifying and screening genes associated with increased longevity and slowed aging |
| 01/21/1999 | WO1999002683A1 Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression |
| 01/21/1999 | WO1999002682A1 p53 MUTANTS FOUND IN TUMORS |
| 01/21/1999 | WO1999002681A1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof |
| 01/21/1999 | WO1999002680A1 New human growth regulator protein |
| 01/21/1999 | WO1999002679A1 Frazzled nucleotide sequences, expression products, compositions and uses |
| 01/21/1999 | WO1999002678A1 Wa545 compositions |
| 01/21/1999 | WO1999002677A1 Gene originating in human chondrocyte |
| 01/21/1999 | WO1999002676A2 Mutants of gef proteins |
| 01/21/1999 | WO1999002675A1 G-coupled receptor showing selective affinity for atp |
| 01/21/1999 | WO1999002674A1 Peptides containing the motif igd and their use as cell migration modulators |
| 01/21/1999 | WO1999002673A2 Antisense oligonucleotide sequences as inhibitors of microorganisms |
| 01/21/1999 | WO1999002672A1 Determination of genetic sex in equine species by analysis of y-chromosomal dna sequences |
| 01/21/1999 | WO1999002671A1 In vitro sorting method |
| 01/21/1999 | WO1999002669A2 Production of polyketides in plants |
| 01/21/1999 | WO1999002668A1 Animal feed with low phytic acid, oil burdened and protein laden grain |
| 01/21/1999 | WO1999002667A1 Mutations in the myostation gene cause double-muscling in mammals |
| 01/21/1999 | WO1999002666A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/21/1999 | WO1999002663A1 Alkaline xyloglucanase |
| 01/21/1999 | WO1999002660A1 Catalytic antibodies for the inactivation of herbicides |
| 01/21/1999 | WO1999002657A1 Rhabdoviruses with reengineered coats |
| 01/21/1999 | WO1999002656A1 Methods and compositions for producing plants and microorganisms that express feedback insensitive threonine dehydratase/deaminase |
| 01/21/1999 | WO1999002655A1 Protein kinases and uses thereof |
| 01/21/1999 | WO1999002654A1 Isolation of bone and cartilage precursor cells |
| 01/21/1999 | WO1999002647A2 Cloning vectors for producing adenoviral minimal viruses |
| 01/21/1999 | WO1999002566A2 Standardised protein |
| 01/21/1999 | WO1999002564A2 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 01/21/1999 | WO1999002563A1 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/21/1999 | WO1999002562A1 Isolated dendritic cell membrane protein genes |
| 01/21/1999 | WO1999002561A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation |
| 01/21/1999 | WO1999002559A1 Reagents and methods useful for detecting diseases of the breast |
| 01/21/1999 | WO1999002556A1 Semaphorin receptors |
| 01/21/1999 | WO1999002552A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 01/21/1999 | WO1999002550A1 Ctl epitopes from ebv |
| 01/21/1999 | WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 01/21/1999 | WO1999002546A1 123 human secreted proteins |
| 01/21/1999 | WO1999002545A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | WO1999002543A1 3'-deoxyribonucleotide derivatives |
| 01/21/1999 | WO1999002266A1 A device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device |
| 01/21/1999 | WO1999002185A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/21/1999 | WO1999002178A1 Therapeutic agent for the treatment of septicaemia, its preparation and use |
| 01/21/1999 | WO1999002174A1 Non-human pdgf-b-deficient transgenic animals with reduced or non-existent numbers of pericytes |
| 01/21/1999 | WO1999002171A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | WO1999002167A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 01/21/1999 | WO1999002030A1 Monoterpene synthases from grand fir (abies grandis) |
| 01/21/1999 | WO1998049312A3 Nucleic acids, proteins, and methods of use of granulocytic erhlichia |
| 01/21/1999 | WO1998048052A3 Amplification based mutation detection |
| 01/21/1999 | WO1998048025A3 Regulatory system for inducible expression of genes with lambdoid promoters |
| 01/21/1999 | WO1998048020A3 Mammalian ubiquitin-isopeptidases that control cell proliferation |
| 01/21/1999 | WO1998046781A3 Novel transgene expression system for increased persistence |
| 01/21/1999 | WO1998046768A3 Phenolic acid esterase and use thereof |
| 01/21/1999 | WO1998046742A3 Dictyocaulus viviparus antigen for the diagnosis of lungworm disease and for vaccination |
| 01/21/1999 | WO1998046273A3 Delivery system for gene therapy to the brain |
| 01/21/1999 | WO1998043657A3 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same |
| 01/21/1999 | WO1998024810A3 Vertebrate homologues of unc-53 protein of c. elegans |
| 01/21/1999 | DE19730786A1 New human neutrophil-lymphocyte peptide and its fragments |
| 01/21/1999 | DE19730535A1 Spezielle Virus-DNA-Fragmente und ihre Verwendung als Promotor Virus specific DNA fragments and their use as promoter |
| 01/21/1999 | DE19730502A1 Verwendung einer Virus-DNA als Promotor Use of a virus as a promoter DNA |
| 01/21/1999 | DE19730066A1 DNA-Sequenz codierend für eine Hydroxyphenylpyruvatdioxygenase und deren Überproduktion in Pflanzen DNA sequence encoding a hydroxyphenylpyruvate and their overproduction in plants |
| 01/21/1999 | CA2792122A1 In vitro sorting method |
| 01/21/1999 | CA2715850A1 Isolated dendritic cell membrane protein genes |
| 01/21/1999 | CA2659180A1 Trichoderma reesei swollenin protein and encoding dna sequences |
| 01/21/1999 | CA2584453A1 A method for increasing the concentration of nucleic acids |
| 01/21/1999 | CA2332636A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | CA2298834A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | CA2296771A1 Method for the identification of synthetic cell- or tissue-specific transcriptional regulatory regions |
| 01/21/1999 | CA2296759A1 Methods and compositions for producing plants and microorganisms that express feedback insensitive threonine dehydratase/deaminase |
| 01/21/1999 | CA2296664A1 Monoterpene synthases from grand fir (abies grandis) |
| 01/21/1999 | CA2296434A1 Mutations in the myostatin gene cause double-muscling in mammals |
| 01/21/1999 | CA2296093A1 Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression |